| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64358-0.2mg | |||
| BSA Free | NB100-64358-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64798-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76740SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35076-1mg | |||
| Carrier-Free | NBP2-35076-100ug | |||
| Carrier-Free | NBP2-35076-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61687-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61726-0.025ml | |||
![Immunohistochemistry-Paraffin: CCR7 Antibody [NLS848] - Analysis of anti-CCR7 antibody with transfected cells expressing CCR7 at 14 ug/ ml.](http://images.novusbio.com/fullsize/CCR7-Antibody-Immunohistochemistry-Paraffin-NLS848-img0008.jpg "Immunohistochemistry-Paraffin: CCR7 Antibody [NLS848] - Analysis of anti-CCR7 antibody with transfected cells expressing CCR7 at 14 ug/ ml.")
![Immunohistochemistry-Paraffin: CCR7 Antibody [NLS848] - Analysis of anti-CCR7 antibody with transfection control at 14 ug/ml.](http://images.novusbio.com/fullsize/CCR7-Antibody-Immunohistochemistry-Paraffin-NLS848-img0002.jpg)
![Immunohistochemistry-Paraffin: CCR7 Antibody [NLS848] - Analysis of anti-CCR7 antibody with human tonsil at dilution: 14 ug/ml](http://images.novusbio.com/fullsize/CCR7-Antibody-Immunohistochemistry-Paraffin-NLS848-img0007.jpg)
![Immunohistochemistry-Paraffin: CCR7 Antibody [NLS848] - Analysis of anti-CCR7 antibody with human spleen at dilution 14 ug/ml.](http://images.novusbio.com/fullsize/CCR7-Antibody-Immunohistochemistry-Paraffin-NLS848-img0006.jpg)
![Flow (Cell Surface): CD48/SLAMF2 Antibody (MEM-102) [NB500-391] - Surface staining of human peripheral blood with anti-CD48 (MEM-102) PE.](http://images.novusbio.com/fullsize/CD48-SLAMF2-Antibody-MEM-102-Flow-Cell-Surface-NB500-391-img0004.jpg "Flow (Cell Surface): CD48/SLAMF2 Antibody (MEM-102) [NB500-391] - Surface staining of human peripheral blood with anti-CD48 (MEM-102) PE.")
![Flow Cytometry: CD48/SLAMF2 Antibody (MEM-102) [NB500-391] - CD48 Antibody (MEM-102) [NB500-391]- Surface staining of human peripheral blood cells with anti-CD48 (MEM-102) Alexa Fluor 700.](http://images.novusbio.com/fullsize/CD48-SLAMF2-Antibody-MEM-102-NB500-391-img0001.jpg)
![Flow (Cell Surface): CD48/SLAMF2 Antibody (MEM-102) [NB500-391] - Surface staining of human peripheral blood with anti-CD48 (MEM-102) biotin / streptavidin-APC.](http://images.novusbio.com/fullsize/CD48-SLAMF2-Antibody-MEM-102-Flow-Cell-Surface-NB500-391-img0002.jpg)
![Flow (Cell Surface): CD48/SLAMF2 Antibody (MEM-102) [NB500-391] - Surface staining of human peripheral blood with anti-CD48 (MEM-102) Pacific BlueTM.](http://images.novusbio.com/fullsize/CD48-SLAMF2-Antibody-MEM-102-Flow-Cell-Surface-NB500-391-img0003.jpg)
![Flow Cytometry: CD3 epsilon Antibody (APA1/1) [NBP1-30426] - Intracellular staining of JURKAT cells with anti-CD3 epsilon activation epitope (APA1/1) PE.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-APA1-1-Flow-Cytometry-NBP1-30426-img0002.jpg "Flow Cytometry: CD3 epsilon Antibody (APA1/1) [NBP1-30426] - Intracellular staining of JURKAT cells with anti-CD3 epsilon activation epitope (APA1/1) PE.")
![Flow Cytometry: CD3 epsilon Antibody (APA1/1) [NBP1-30426] - Intracellular staining of human peripheral blood with anti-CD3 epsilon activation epitope (APA1/1) purified, GAM-FITC.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-APA1-1-Flow-Cytometry-NBP1-30426-img0001.jpg)
![Western Blot: CD27/TNFRSF7 Antibody (JB40-98) [NBP2-75434] - Analysis of CD27 on Raji cell using anti-CD27 antibody at 1/500 dilution.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-JB40-98-Western-Blot-NBP2-75434-img0005.jpg "Western Blot: CD27/TNFRSF7 Antibody (JB40-98) [NBP2-75434] - Analysis of CD27 on Raji cell using anti-CD27 antibody at 1/500 dilution.")
![Immunocytochemistry/Immunofluorescence: CD27/TNFRSF7 Antibody (JB40-98) [NBP2-75434] - Staining CD27 in K562 cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-JB40-98-Immunocytochemistry-Immunofluorescence-NBP2-75434-img0002.jpg)
![Immunohistochemistry-Paraffin: CD27/TNFRSF7 Antibody (JB40-98) [NBP2-75434] - Analysis of paraffin-embedded rat spleen tissue using anti-CD27 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-JB40-98-Immunohistochemistry-Paraffin-NBP2-75434-img0004.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (JB40-98) [NBP2-75434] - Analysis of Daudi cells with CD27 antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti rabbit IgG was used as the secondary antibody.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-JB40-98-Flow-Cytometry-NBP2-75434-img0001.jpg)
![Immunohistochemistry-Paraffin: CD27/TNFRSF7 Antibody (JB40-98) [NBP2-75434] - Analysis of paraffin-embedded human tonsil tissue using anti-CD27 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-JB40-98-Immunohistochemistry-Paraffin-NBP2-75434-img0003.jpg)
![Flow Cytometry: HLA DQ/DR/DP Antibody (WR18) [NB100-64358] - Staining of human peripheral blood lymphocytes.](http://images.novusbio.com/fullsize/HLA-DQ-DR-DP-Antibody-WR18-Flow-Cytometry-NB100-64358-img0001.jpg "Flow Cytometry: HLA DQ/DR/DP Antibody (WR18) [NB100-64358] - Staining of human peripheral blood lymphocytes.")
![Immunocytochemistry/Immunofluorescence: IL-4 Antibody (BVD4-1D11) [NB100-64798] - Analysis of expression of IL-4 and IL-4 type II receptor subunits in undifferentiated mouse ESCs and mouse primary myoblasts. Representative images of immunocytochemistry analysis of IL-4Ralpha, IL-13Ralpha1, and IL-4 in mouse primary myoblasts at day 6 (white arrows indicate myoblasts, grey arrows indicate myotubes). Scale bar: 20 um. Image collected and cropped by CiteAb from the following publication (//www.mdpi.com/1422-0067/20/16/3932), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/IL-4-Antibody-BVD4-1D11-Immunocytochemistry-Immunofluorescence-NB100-64798-img0003.jpg "Immunocytochemistry/Immunofluorescence: IL-4 Antibody (BVD4-1D11) [NB100-64798] - Analysis of expression of IL-4 and IL-4 type II receptor subunits in undifferentiated mouse ESCs and mouse primary myoblasts. Representative images of immunocytochemistry analysis of IL-4Ralpha, IL-13Ralpha1, and IL-4 in mouse primary myoblasts at day 6 (white arrows indicate myoblasts, grey arrows indicate myotubes). Scale bar: 20 um. Image collected and cropped by CiteAb from the following publication (//www.mdpi.com/1422-0067/20/16/3932), licensed under a CC-BY license.")
![Immunocytochemistry/Immunofluorescence: IL-4 Antibody (BVD4-1D11) [NB100-64798] - Analysis of expression of IL-4 and IL-4 type II receptor subunits in undifferentiated mouse ESCs and mouse primary myoblasts. Representative images of immunocytochemistry analysis of IL-4Ralpha, IL-13Ralpha1, and IL-4 in undifferentiated ESCs. Scale bar: 20 um. Scale bar: 20 um. Image collected and cropped by CiteAb from the following publication (mdpi.com/1422-0067/20/16/3932), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/IL-4-Antibody-BVD4-1D11-Immunocytochemistry-Immunofluorescence-NB100-64798-img0004.jpg)
![Western Blot: IL-4 Antibody (BVD4-1D11) [NB100-64798] - Analysis of mouse IL-4 recombinant protein probed with RAT ANTI MOUSE INTERLEUKIN-4 followed by F(ab')2 RABBIT ANTI RAT IgG:HRP.](http://images.novusbio.com/fullsize/IL-4-Antibody-BVD4-1D11-Western-Blot-NB100-64798-img0002.jpg)
![Western Blot: IL-21 Antibody [NBP1-76740] - Western Blot Validation with Recombinant Protein.Loading: 30 ng of human IL-21 recombinant protein per lane.Antibodies: IL-21 NBP1-76740 (0.5 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/IL-21-Antibody-Western-Blot-NBP1-76740-img0007.jpg "<b>Expression of Tagged Proteins Validation. </b>Western Blot: IL-21 Antibody [NBP1-76740] - Western Blot Validation with Recombinant Protein.Loading: 30 ng of human IL-21 recombinant protein per lane.Antibodies: IL-21 NBP1-76740 (0.5 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.")
![<b>Expression of Tagged Proteins Validation. </b>Immunocytochemistry/Immunofluorescence: IL-21 Antibody [NBP1-76740] - Immunocytochemistry Validation of IL-21 in K562 Cells.Immunocytochemical analysis of K562 cells using anti-IL-21 antibody (NBP1-76740) at 2 ug/mL. Cells were fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.](http://images.novusbio.com/fullsize/IL-21-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-76740-img0008.jpg)
![Western Blot: IL-21 Antibody [NBP1-76740] - Western Blot Validation in Human, Mouse and Rat Cell Lines.Loading: 15 ug of lysates per lane.Antibodies: IL-21 NBP1-76740, (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/IL-21-Antibody-Western-Blot-NBP1-76740-img0004.jpg)
![<b>Independent Antibodies Validation. </b>Western Blot: IL-21 Antibody [NBP1-76740] - Independent Antibody Validation (IAV) via Protein Expression Profile in Cell Lines.Loading: 15 ug of lysates per lane.Antibodies: IL-21 NBP1-76740 (1 ug/mL), IL-21 from Company B (5 ug/mL), beta-actin (5 ug/mL) and beta-actin (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/IL-21-Antibody-Western-Blot-NBP1-76740-img0005.jpg)
![Western Blot: IL-21 Antibody - BSA Free [NBP1-76740] - Figure 3 Western Blot Validation in Human HL-60 Cell LysateLoading: 15 u of lysates per lane.Antibodies: IL-21 (1 u/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.(A) Absence of blocking peptide(B) Presence of blocking peptide.](http://images.novusbio.com/fullsize/nbp1-76740_rabbit-polyclonal-il-21-antibody-271120241937752.jpg)
![Western Blot: ORAI3 Antibody [NBP2-82013] - Western blot analysis of ORAI3 in A20 cell lysate with ORAI3 antibody at (A) 1, (B) 2 and (C) 4 ug/mL.](http://images.novusbio.com/fullsize/ORAI3-Antibody-Western-Blot-NBP2-82013-img0001.jpg "Western Blot: ORAI3 Antibody [NBP2-82013] - Western blot analysis of ORAI3 in A20 cell lysate with ORAI3 antibody at (A) 1, (B) 2 and (C) 4 ug/mL.")
![Immunohistochemistry: ORAI3 Antibody - BSA Free [NBP2-82013] - Immunohistochemistry of ORAI3 in mouse spleen tissue with ORAI3 antibody at 2 u/mL.](http://images.novusbio.com/fullsize/nbp2-82013_rabbit-polyclonal-orai3-antibody-271120241918645.gif)
![Immunocytochemistry/ Immunofluorescence: ORAI3 Antibody - BSA Free [NBP2-82013] - Immunocytochemistry of ORAI3 in A20 cells with ORAI3 antibody at 10 u/mL.](http://images.novusbio.com/fullsize/nbp2-82013_rabbit-polyclonal-orai3-antibody-2711202420441150.jpg)
![Western Blot: Carboxylesterase 1/CES1 Antibody (7C9R6) [NBP3-15388] - Western blot analysis of extracts of various cell lines, using Carboxylesterase 1/CES1 Rabbit mAb (NBP3-15388) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.](http://images.novusbio.com/fullsize/Carboxylesterase-1-CES1-Antibody-7C9R6-Western-Blot-NBP3-15388-img0002.jpg "Western Blot: Carboxylesterase 1/CES1 Antibody (7C9R6) [NBP3-15388] - Western blot analysis of extracts of various cell lines, using Carboxylesterase 1/CES1 Rabbit mAb (NBP3-15388) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.")
![Immunocytochemistry/Immunofluorescence: Carboxylesterase 1/CES1 Antibody (7C9R6) [NBP3-15388] - Immunofluorescence analysis of HeLa cells using Carboxylesterase 1/CES1 Rabbit mAb (NBP3-15388) at dilution of 1:100 (40x lens). Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/Carboxylesterase-1-CES1-Antibody-7C9R6-Immunocytochemistry-Immunofluorescence-NBP3-15388-img0001.jpg)
![Western Blot: Carboxylesterase 1/CES1 Antibody (7C9R6) [NBP3-15388] - Western blot analysis of extracts of HepG2 cells, using Carboxylesterase 1/CES1 Rabbit mAb (NBP3-15388) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.](http://images.novusbio.com/fullsize/Carboxylesterase-1-CES1-Antibody-7C9R6-Western-Blot-NBP3-15388-img0003.jpg)
![Immunocytochemistry/ Immunofluorescence: Carboxylesterase 1/CES1 Antibody (7C9R6) [Carboxylesterase 1/CES1] - Confocal imaging of paraffin-embedded Mouse liver tissue using Carboxylesterase 1/CES1 Rabbit mAb followed by a further incubation with Cy3 Goat Anti-Rabbit IgG (H+L) . DAPI was used for nuclear staining (Blue). Objective: 40x. Perform high pressure antigen retrieval with 0.01 M citrate buffer (pH 6.0) prior to IF staining.](http://images.novusbio.com/fullsize/nbp3-15388_rabbit-carboxylesterase-1-ces1-mab-7c9r6-52202517202984.jpg)
![Immunocytochemistry/ Immunofluorescence: Carboxylesterase 1/CES1 Antibody (7C9R6) [Carboxylesterase 1/CES1] - Confocal imaging of paraffin-embedded Rat liver tissue using Carboxylesterase 1/CES1 Rabbit mAb followed by a further incubation with Cy3 Goat Anti-Rabbit IgG (H+L) . DAPI was used for nuclear staining (Blue). Objective: 40x. Perform high pressure antigen retrieval with 0.01 M citrate buffer (pH 6.0) prior to IF staining.](http://images.novusbio.com/fullsize/nbp3-15388_rabbit-carboxylesterase-1-ces1-mab-7c9r6-52202517284992.jpg)
![SDS-Page: Human TNF-alpha Protein [NBP2-35076]](http://images.novusbio.com/fullsize/Human-TNF-alpha-Protein-SDS-Page-NBP2-35076-img0001.jpg "SDS-Page: Human TNF-alpha Protein [NBP2-35076]")
![Western Blot: KIR3DL1 Antibody (2C3B6) [NBP2-61687] - Analysis using CD158E1 mAb against human CD158E1 (AA: extra 206-340) recombinant protein. (Expected MW is 40.5 kDa)](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-2C3B6-Western-Blot-NBP2-61687-img0004.jpg "Western Blot: KIR3DL1 Antibody (2C3B6) [NBP2-61687] - Analysis using CD158E1 mAb against human CD158E1 (AA: extra 206-340) recombinant protein. (Expected MW is 40.5 kDa)")
![Immunohistochemistry: KIR3DL1 Antibody (2C3B6) [NBP2-61687] - Analysis of paraffin-embedded cervical cancer tissues using CD158E1 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-2C3B6-Immunohistochemistry-NBP2-61687-img0003.jpg)
![Flow Cytometry: KIR3DL1 Antibody (2C3B6) [NBP2-61687] - Analysis of HL-60 cells using CD158E1 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-2C3B6-Flow-Cytometry-NBP2-61687-img0002.jpg)
![Western Blot: KIR3DL1 Antibody (2C3B6) [NBP2-61687] - Analysis using CD158E1 mAb against HEK293 (1) and CD158E1 (AA: extra 206-340)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-2C3B6-Western-Blot-NBP2-61687-img0005.jpg)
![ELISA: KIR3DL1 Antibody (2C3B6) [NBP2-61687] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-2C3B6-ELISA-NBP2-61687-img0001.jpg)
![Western Blot: CD1c/BDCA-1 Antibody (2A7C11) [NBP2-61726] - Analysis using CD1C mAb against human CD1C (AA: extra 18-302) recombinant protein. (Expected MW is 58.1 kDa)](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-2A7C11-Western-Blot-NBP2-61726-img0004.jpg "Western Blot: CD1c/BDCA-1 Antibody (2A7C11) [NBP2-61726] - Analysis using CD1C mAb against human CD1C (AA: extra 18-302) recombinant protein. (Expected MW is 58.1 kDa)")
![Immunohistochemistry-Paraffin: CD1c/BDCA-1 Antibody (2A7C11) [NBP2-61726] - Analysis of cervical cancer tissues using CD1C mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-2A7C11-Immunohistochemistry-NBP2-61726-img0003.jpg)
![Flow Cytometry: CD1c/BDCA-1 Antibody (2A7C11) [NBP2-61726] - Analysis of Ramos cells using CD1C mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-2A7C11-Flow-Cytometry-NBP2-61726-img0002.jpg)
![Western Blot: CD1c/BDCA-1 Antibody (2A7C11) [NBP2-61726] - Analysis using CD1C mAb against HEK293 (1) and CD1C (AA: extra 18-302)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-2A7C11-Western-Blot-NBP2-61726-img0005.jpg)
![ELISA: CD1c/BDCA-1 Antibody (2A7C11) [NBP2-61726] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-2A7C11-ELISA-NBP2-61726-img0001.jpg)